The clearance enables a collaboration agreement with Waldemar Link GmbH & Co. KG, to progress. It adds the LinkSymphoKnee from Waldemar Link to the Think Surgical ID-Hub, a proprietary data bank of implant modules. They work with the open-platform version of the TMINI system.
“Think Surgical is excited to add the LinkSymphoKnee to the TMINI System. The open platform version of TMINI is now available with eight different knee designs from eight separate orthopedic companies offering surgeons the choice of single-radius, anatomic, and guided motion knees on a single robotic platform.” said Stuart Simpson, president and CEO.
TMINI received FDA clearance in May 2023. It features a wireless, robotic handpiece that assists surgeons in performing total knee replacement. Following a CT-based three-dimensional surgical plan, the TMINI robotic handpiece automatically compensates for the surgeon’s hand movement to locate bone pins along precisely defined planes. Cutting guides are then connected to the bone pins for accurate bone resection.
Part of the company’s offering includes a commitment to providing open-platform robots. It aims to support implants from multiple manufacturers, adding Link implants to its ID-HUB database. The company says this further enhances the options available to surgeons using TMINI.
Think Surgical offers surgical robots that support implants from multiple manufacturers. This latest clearance follows FDA clearance for use with Zimmer Biomet’s Persona Knee in September, clearance for TMINI with Medacta knee systems in August, plus clearance for new software in July. The company has since added a number of implant options to its system. That includes collaborations with Maxx Orthopedics, b-ONE Ortho and Signature Orthopaedics.
